Picture Campus Berlin-Buch GmbH CBB Location of Future Innovation 650x100px

News > All

Total search results: 6897 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 ... 67 68 69  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Valneva S.E.. (4/25/22). "Press Release: Valneva Provides Regulatory Update on its inactivated COVID-19 Vaccine Candidate". Saint-Herblain. 2022-04-25
Biotest AG. (4/25/22). "Press Release: Grifols Acquires Majority of Voting Rights in Biotest". Dreieich. 2022-04-25
SHS Gesellschaft für Beteiligungsmanagement mbH. (4/22/22). "Press Release: SHS and Yabeo Invest in the Leading Scandinavian Digital Health Platform Dr.Dropin". Tübingen & Oslo. 2022-04-22
Eppendorf SE. (4/22/22). "Press Release: Eppendorf Builds New Site in Wismar for High-tech Polymers Used in Laboratories". Wismar & Hamburg. 2022-04-22
Bayer AG. (4/22/22). "Press Release: Bayer to Create Ag Biologicals Powerhouse Partnership with Ginkgo Bioworks, Advancing Joyn Bio Technology Platforms". Monheim. 2022-04-22
SHS Gesellschaft für Beteiligungsmanagement mbH. (4/21/22). "Press Release: SHS Sells Shares in Bochum-based Phenox GmbH, a Leading Manufacturer of Instruments and Implants for the Treatment of Stroke". Tübingen. 2022-04-21
CureVac N.V.. (4/21/22). "Press Release: CureVac and GSK’s Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study". Tübingen & Boston, MA. 2022-04-21
Bayer AG. (4/2122). "Press Release: Bayer Appoints Tara Frenkl as the New Head of Oncology Development at Its Oncology Strategic Business Unit". Berlin. 2022-04-21
VIB, Flanders Interuniversity Institute of Biotechnology. (4/20/22). "Press Release: Christine Durinx Joins VIB as Co-Managing Director". 2022-04-20
Carl Zeiss Meditec AG. (4/19/22). "Press Release: Carl Zeiss Meditec Acquires Two Manufacturers of Surgical Instruments". Jena. 2022-04-19
Symrise AG. (4/14/22). "Press Release: Symrise Successfully Places €750 million ESG-linked Promissory Loan Notes". Holzminden. 2022-04-14
CDR-Life AG. (4/13/22). "Press Release: CDR-Life Announces $76 Million Raised in Series A Funding". Zürich. 2022-04-13
Bayer AG. (4/13/22). "Press Release: Bayer Receives Approval for Precision Oncology Treatment Vitrakvi in China [Not intended for U.S. and UK Media]". Berlin. 2022-04-13
Cimeio Therapeutics AG. (4/13/22). "Press Release: Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A". Basel & Boston, MA. 2022-04-13
Oxford BioTherapeutics Ltd.. (4/13/22). "Press Release: Oxford BioTherapeutics Grants Third Exclusive License to Boehringer Ingelheim for Development and Commercialization of Antibody Products to a Novel Oncology Target". Oxford & San Jose, CA. 2022-04-13
Affimed N.V.. (4/13/22). "Press Release: Affimed Announces Pricing of Upsized $90 Million Public Offering of Common Shares". Heidelberg. 2022-04-13
Affimed N.V.. (4/12/22). "Press Release: Affimed Announces Proposed Public Offering of Common Shares". Heidelberg. 2022-04-12
BioNTech SE. (4/11/22). "Press Release: BioNTech and Matinas BioPharma Announce Exclusive Research Collaboration to Evaluate Novel Delivery Technology for mRNA-based Vaccines". Mainz & Beminster, NJ. 2022-04-11
CureVac N.V.. (4/11/22). "Press Release: CureVac and GSK Enter into Pandemic Preparedness Contract with German Government". Tübingen & Boston, MA. 2022-04-11
Affimed N.V.. (4/10/22). "Press Release: Affimed Presents Updated Clinical Data from Phase 1/2 Study of AFM13 Precomplexed with Cord Blood-Derived NK Cells at AACR Annual Meeting". Heidelberg. 2022-04-10
Mireca Medicines GmbH. (4/8/22). "Press Release: Mireca Signs Transformative Deal with Nasdaq-listed Graybug Vision". Tübingen. 2022-04-08
H. Lundbeck A/S. (4/8/22). "Press Release: Joerg Hornstein to Join Lundbeck as Chief Financial Officer and Head of Corporate Functions". Valby. 2022-04-08
Affimed N.V.. (4/8/22). "Press Release: Affimed Presents Findings from the Dose-escalation Phase of the First-in-human Study of AFM24 in Patients with EGFR-positive Solid Tumors". Heidelberg. 2022-04-08
IonSense, Inc.. (4/7/22). "Press Release: IonSense, a Leader In DART Mass Spectroscopy, Announces Acquisition by Bruker to Accelerate DART-MS Methods and Applications Development". New York, NY, London & Research Triangle Park, NC. 2022-04-07
Balderton Capital. (4/6/22). "Press Release: Avi Medical Raises €50M to Put Preventative Healthcare and Digital Integration at Heart of Its Service". 2022-04-06
ViGeneron GmbH. (4/6/22). "Press Release: ViGeneron Signs Gene Therapy Strategic Collaboration and Option Agreement with Regeneron for One Inherited Retinal Disease Target". Munich. 2022-04-06
NanoTemper Technologies GmbH. (4/6/22). "Press Release: NanoTemper Technologies and PharmAI Launch Proto, a Free AI Tool to Quickly Determine which Protein Labeling Strategy Works Best for Molecular Interaction Measurements". Munich & Dresden. 2022-04-06
Catalent, Inc.. (4/6/22). "Press Release: Catalent Acquires Facility in Oxfordshire to Expand Biologics Capabilities in the UK and Across Europe". Somers, NJ. 2022-04-06
Merck KGaA. (4/5/22). "Press Release: Merck Advances BioProcessing Capabilities with Acquisition of MAST Platform from Lonza, a Leading Automated Bioreactor Sampling System". Darmstadt. 2022-04-05
Bruker Corporation. (4/5/22). "Press Release: Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies". Billerica, MA. 2022-04-05
Labster ApS. (4/4/22). "Press Release: Labster Secures $47M in New Funding Tranche to Expand Global Opportunities for Virtual Science Laboratory Simulations". Copenhagen & Boston, MA. 2022-04-04
Oxford Gene Technology Ltd.. (4/4/22). "Press Release: OGT Welcomes Adrian Smith as CEO". Oxford. 2022-04-04
AXA Investment Managers. (4/4/22). "Press Release: AXA IM Alts Launches $500 Million Private Equity Healthcare Strategy alongside Two Senior Appointments". 2022-04-04
Novartis AG. (4/4/22). "Press Release (Ad hoc): Novartis Announces New Organizational Structure to Accelerate Growth, Strengthen Pipeline and Increase Productivity". Basel. 2022-04-04
Biovox GmbH. (4/22). "Press Release: Successful Pre-Seed-Round for BIOVOX". 2022-04-01
Bayer AG. (4/1/22). "Press Release: Breakthrough Innovation Forum. Bayer Set to Drive Breakthrough Innovations in the Life Sciences". Leverkusen. 2022-04-01
Bayer AG. (3/31/22). "Press Release: Bayer to Strengthen Global Pharmaceuticals Production Network. Planned Investments of around €2bn over Next Three Years [Not intended for U.S. and UK Media]". Berlin. 2022-03-31
Oxford Science Enterprises. (3/31/22). "Press Release: Oxford Science Enterprises Strengthens Investment Teams with Two New Appointments". 2022-03-31
Affimed N.V.. (3/31/22). "Press Release: Affimed Reports 2021 Financial Results and Highlights Recent Operational Progress". Heidelberg. 2022-03-31
High-Tech Gründerfonds Management GmbH. (3/31/22). "Press Release: Improving ARDS Treatment with Digital Twins. Ebenbuild Secures Seed Financing Round Led by Bayern Kapital and High-Tech Gründerfonds". Munich, Bonn & Landshut. 2022-03-31
Cytosurge AG. (3/30/22). "Press Release: Cytosurge Launches Cell Line Engineering Services Based on Proprietary FluidFM Technology". Zurich. 2022-03-30
VectivBio Holding AG. (3/30/22). "Press Release: VectivBio Announces Japan License Deal and Loan Facility Agreement, Providing up to $117 Million to Fuel the Company Through Key Catalysts". Basel. 2022-03-30
CureVac N.V.. (3/30/22). "Press Release: CureVac and GSK Start Clinical Development of Second-generation COVID-19 Vaccine Candidate, CV2CoV". Tübingen & Boston, MA. 2022-03-30
Neuron23 Inc.. (3/30/22). "Press Release: Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease". South San Francisco, CA. 2022-03-30
XAnge (Alexis du Peloux). (3/29/22). "Press Release (Blog Post): Core Biogenesis – When a Deeptech Goes Faster than Eexpected, Let’s Speed Up!". 2022-03-29
Core Biogenesis S.A.S.. (3/29/22). "Press Release: Core Biogenesis Raises €10M from XAnge and Blue Horizon Ventures to Accelerate Treatment of Cancer and Neurodegenerative Diseases". 2022-03-29
Sanofi S.A.. (3/29/22). "Press Release: Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets". Paris. 2022-03-29
Irubis GmbH. (3/24/22). "Press Release: Irubis Receives 500k € as Convertible Loan from the EIC Fund, the Equity Instrument of the “EIC Accelerator Pilot”, under HORIZON 2020 Program". Munich. 2022-03-24
European Invesmtent Bank (EIB). (3/24/22). "Press Release: Austria – EIB Supports Innovacell’s Innovative Cell Therapy for Treating Incontinence". 2022-03-24
Lonza Group Ltd.. (3/23/22). "Press Release: Christian Seufert Appointed as President of Capsules and Health Ingredients Division". Basel. 2022-03-23
Immatics N.V.. (3/23/22). "Press Release: Immatics Announces Full Year 2021 Financial Results and Corporate Update". Tübingen & Houston, TX. 2022-03-23
Bayer AG. (3/22/22). "Press Release: Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations". Tel Aviv. 2022-03-22
Nucleai MD. (3/22/22). "Press Release: Nucleai Closes $33 Million Series B Financing to Advance Spatial Biology Platform for Drug Research, Development and Diagnostics". Tel Aviv. 2022-03-22
Veraxa Biotech GmbH. (3/22/22). "Press Release: Torsten Buergermeister Joins Veraxa Biotech GmbH as Chief Financial Officer". Heidelberg. 2022-03-22
ITM Isotope Technologies Munich SE. (3/22/22). "Press Release: ITM Receives EUR 33 Million Equity Investment to Advance Precision Oncology Pipeline of Targeted Radiopharmaceuticals". Garching. 2022-03-22
Nagi Bioscience S.A.. (3/21/22). "Press Release: The SERI-funded EIC Accelerator Program Grants Nagi Bioscience with €2.5 Million to Accelerate Development and Commercial Scale-up of Their Unique ‘Organism-on-Chip’ Product". Lausanne. 2022-03-21
Bavarian Nordic A/S. (3/21/22). "Press Release: Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets 2022-03-21
Evotec SE. (3/21/22). "Press Release: Evotec Receives €3m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme". Hamburg. 2022-03-21
BigOmics Analytics S.A.. (3/17/22). "Press Release: BigOmics Closes Pre-Series A with Additional Investment from Eppendorf". Lugano. 2022-03-17
Bruker Corporation. (3/16/22). "Press Release: Bruker Appoints Philip Ma to Its Board of Directors". Billerica, MA. 2022-03-16
Gilde Healthcare Partners. (3/16/22). "Press Release: Gilde Healthcare Raises more than €500 Million for Private Equity Investments in European Healthcare Companies". Utrecht. 2022-03-16
Immunic, Inc.. (3/16/22). "Press Release: Immunic, Inc. Announces Promotion of Glenn Whaley, CPA to Chief Financial Officer". New York, NY. 2022-03-16
Bruker Corporation. (3/15/22). "Press Release: Bruker Leads $46 Million New Financing Round for PrognomiQ to Advance Development of Next-Generation Multi-omics Liquid Biopsy Products for Cancer". San Mateo, CA. 2022-03-15
Adrenomed AG. (3/15/22). "Press Release: Adrenomed Supervisory Board Appoints Dr. Richard Jones as CEO". Hennigsdorf. 2022-03-15
Temedica GmbH. (3/15/22). "Press Release: Temedica Announces Cooperation with Bristol Myers Squibb for the Development of a Digital Companion for Psoriasis Patients". Munich. 2022-03-15
InfanDx AG. (3/15/22). "Press Release: Neonatal Diagnostics Company InfanDx AG Closes Oversubscribed Second Tranche of Series A". Cologne & Boston, MA. 2022-03-15
Ayoxxa Biosystems GmbH. (3/14/22). "Press Release: Ayoxxa Receives Fresh Capital for Commercial Growth in Europe, US and Asia Led by Prosnav Capital". Cologne. 2022-03-14
Ginkgo Bioworks Inc.. (3/14/22). "Press Release: Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-high-throughput Screening Platform". Boston, MA & Basel. 2022-03-14
Forbion Capital Partners. (3/14/22). "Press Release: Forbion Strengthens Its Team with the Appointments of Mathias Vinther and Vanessa Carle". Naarden. 2022-03-14
MedXCell S.A.. (3/11/22). "Press Release: MedXCell SA Is Proud to Annonce the Arrival of Andrew Galzaka and John D. McMannis as New Members of the Board and Pierre J.Magistretti as New Scientific Advisor". Montreux. 2022-03-11
Scenic Biotech B.V.. (3/10/22). "Press Release: Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases". Amsterdam. 2022-03-10
Heidelberg Pharma AG. (3/10/22). "Press Release: Heidelberg Pharma Receives Milestone Payment from Partner Magenta for Dosing the First Patient with MGTA-117". Ladenburg. 2022-03-10
MorphoSys AG. (3/10/22). "Press Release (Ad hoc): MorphoSys AG Reports Non-cash Impairment Charge of approx. € 231 Million on Goodwill after Consolidation of Research and Discovery Functions, Corresponding Increase of Group Operating Expenses in 2021". P 2022-03-10
Solvias AG. (3/8/22). "Press Release: Solvias Appoints Archie Cullen Chief Executive Officer". Kaiseraugst. 2022-03-08
Vaximm AG. (3/8/22). "Press Release: NEC OncoImmunity Acquires Vaximm’s Neoantigen Vaccine Development Assets". Oslo, Tokyo, Basel & Mannheim. 2022-03-08
Enzymicals AG. (3/8/22). "Press Release: Enzymicals AG Board of Supervisors Appoints New Management with Dr. Erik de Vries as CEO". Greifswald. 2022-03-08
BioNTech SE. (3/8/22). "Press Release: BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo (cemiplimab) Combination in NSCLC". Mainz. 2022-03-08
LenioBio GmbH. (3/7/22). "Press Release: LenioBio Closes Its Series-A Extension Round and Strengthens Its Board of Directors". Düsseldorf. 2022-03-07
Kurma Partners. (3/7/22). "Press Release: Kurma Partners Targets €250 Million for its First Growth Opportunities Fund". Paris. 2022-03-07
Singleron Biotechnologies. (3/7/22). "Press Release: Singleron Acquires Proteona". Nanjing, Suzhou, Cologne & Singapore. 2022-03-07
Enamine Ltd.. (3/7/22). "Press Release: Open Letter from Enamine Founder and CEO Dr. Andrey Tolmachov". 2022-03-07
InxMed Co., Ltd.. (3/4/22). "Press Release: InxMed Raised $50 Million in Series B Financing to Advance Innovative Therapies to Drug-resistance Cancers". Nanjing. 2022-03-04
ArrePath. (3/3/22). "Press Release: ArrePath Announces $20 Million Seed Financing to Advance its Machine Learning-based Platform for Discovery of Novel Anti-infectives Addressing Antimicrobial Resistance". Princeton, NJ. 2022-03-03
Epsilogen Ltd.. (3/2/22). "Press Release: Epsilogen Announces Completion of Oversubscribed £30.75 Million ($41.20 Million) Series B Financing". London. 2022-03-02
CureVac N.V.. (3/1/22). "Press Release: CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer". Tübingen & Boston, MA. 2022-03-01
EQT AB. (3/1/22). "Press Release: EQT Closes Acquisition of LSP and Introduces EQT Life Sciences". 2022-03-01
ECBF Management GmbH. (3/1/22). "Press Release: €34M to End Chick Culling. Impact Fund ECBF Invests In AgTech In Ovo". Luxembourg. 2022-03-01
Ampersand Capital Partners. (3/1/22). "Press Release: BioEcho Life Sciences Receives Growth Equity Investment from Ampersand Capital Partners". Cologne. 2022-03-01
Heidelberg Pharma AG. (2/28/22). "Press Release: Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment". Ladenburg. 2022-02-28
Evolva Holding S.A.. (2/28/22). "Press Release: Carsten Däweritz Remains CFO of Evolva". Reinach. 2022-02-28
Editas Medicine, Inc.. (2/28/22). "Press Release: Editas Medicine Announces Favorable Decision from U.S. Patent and Trademark Office in CRISPR Patent Interference". Cambridge, MA. 2022-02-28
Memo Therapeutics AG. (2/26/22). "Press Release: Memo Therapeutics AG Closes Series B Financing at CHF37 Million Following Oversubscribed CHF23 Million Extension". Schlieren. 2022-02-26
Medigene AG. (2/25/22). "Press Release: Dr. Selwyn Ho Appointed New CEO of Medigene". Lisbon. 2022-02-25
Celeris Therapeutics GmbH. (2/24/22). "Press Release: CelerisTx Appoints Pharmaceuticals Industry Leader Peter Ho, M.D., Ph.D., to the Board of Directors". Menlo Park, CA. 2022-02-24
ECBF Management GmbH. (2/23/22). "Press Release: Growth Capital for Sustainable Transformation to a Bio-based Circular Economy. EU-initiated Impact Fund Oversubscribed with € 300 million". Luxembourg. 2022-02-23
Poseida Therapeutics, Inc.. (2/22/22). "Press Release: Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy". San Diego, CA. 2022-02-22
BioNTech SE. (2/21/22). "Press Release: BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer". Mainz & Martinsried. 2022-02-21
Valneva S.E.. (2/21/22). "Press Release: Valneva Awarded Up to £20 Million by Scottish Enterprise to Advance Vaccine Development". Saint-Herblain. 2022-02-21
FZI Forschungszentrum Informatik. (2/21/22). "Press Release: Busy Bees in Search of Data. OCELI Project Makes Causes of Bee Mortality Measurable". Karlsruhe. 2022-02-21
Vibalogics GmbH. (2/18/22). "Press Release: Vibalogics Acquired by Top Global CDMO Recipharm AB". 2022-02-18
next pagenext page 1 2 3 4 5 ... 67 68 69  next pagenext page


Picture [iito] Männer Ballett 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group Biotech Showcase 2023 San Francisco 650x300px

» top